Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Elite Pharmaceuticals Inc (OTCQB:ELTP)

0.2252
Delayed Data
As of Aug 03
 -0.0108 / -4.58%
Today’s Change
0.17
Today|||52-Week Range
0.40
-0.35%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues2.4M3.4M4.6M5.0M
 
 
 
 
 
Cost of Goods Sold735.8K2.0M3.2M3.0M
 
 
 
 
 
Depreciation And Amortization484.2K423.3K500.9K617.0K
 
 
 
 
 
 
Operating ExpensesGross Income1.2M971.5K864.4K1.4M
 
 
 
 
 
General Expenses3.2M2.5M6.1M17.9M
 
 
 
 
 
Research And Development1.7M975.3K4.0M14.7M
 
 
 
 
 
Total Operating Expenses4.4M5.0M9.9M21.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-2.0M-1.6M-5.3M-16.5M
 
 
 
 
 
Extraordinary Credit0.003.5M0.0044.0M
 
 
 
Extraordinary Charge-12.7M0.00-90.7M0.00
 
 
 
Interest Expense On Debt654.1K393.0K899.9K287.2K
 
 
 
 
 
Other Expenses-250.0K-437.5K19.8K1.7M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-15.5M1.1M-96.9M28.9M
 
 
 
 
 
Income Taxes-484.0K-353.7K-292.6K-3.2K
 
 
 
 
 
Net Income-15.2M1.5M-96.6M28.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS259.2M349.1M463.0M591.2M
 
 
 
 
 
Shares To Calculate EPS Diluted259.2M526.9M463.0M757.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.06$0.00-$0.21-$0.02
 
 
 
 
EPS Diluted-$0.06-$0.00-$0.21-$0.02